Abstract 4211: Minocycline-based metronomic therapy as a novel approach to enhance anti-tumor immune responses and reduce tumor burden in mouse models of colorectal cancer

Authors

• Salome V. Ibba, LSU Health Sciences Center - New Orleans
• Hanh Luu, LSU Health Sciences Center - New Orleans
• Mohamed Ghonim, LSU Health Sciences Center - New Orleans
• Cecilia Vittori, LSU Health Sciences Center - New OrleansFollow
• Matthew J. Dean, LSU Health Sciences Center - New Orleans
• Giulia Monticone, LSU Health Sciences Center - New OrleansFollow
• Francesca Peruzzi, LSU Health Sciences Center - New OrleansFollow
• Augusto Ochoa, LSU Health Sciences Center - New OrleansFollow
• Lucio Miele, LSU Health Sciences Center - New OrleansFollow
• Hamid Boulares, LSU Health Sciences Center - New OrleansFollow

Document Type

Conference Proceeding

Publication Date

6-15-2022

Publication Title

Cancer Research

Abstract

Proceedings of the American Association for Cancer Research Annual Meeting 2022; Apr 8 - 13, 2022; Philadelphia, PA

Volume

82

Issue

12, Supplement

Publisher

American Association for Cancer Research

Comments

Abstract 4211

Rights

©2022 American Association for Cancer Research

Recommended Citation

Ibba, Salome V.; Luu, Hanh; Ghonim, Mohamed; Vittori, Cecilia; Dean, Matthew J.; Monticone, Giulia; Peruzzi, Francesca; Ochoa, Augusto; Miele, Lucio; and Boulares, Hamid, "Abstract 4211: Minocycline-based metronomic therapy as a novel approach to enhance anti-tumor immune responses and reduce tumor burden in mouse models of colorectal cancer" (2022). School of Graduate Studies Faculty Publications. 544.
https://digitalscholar.lsuhsc.edu/sogs_facpubs/544
10.1158/1538-7445.AM2022-4211